In an effort to raise awareness for aiding children with Leukemia, Central Payment conducted a company wide bone marrow drive in early January 2010.
December 22, 2010 (Newswire) - In an effort to raise awareness for aiding children with Leukemia, Central Payment conducted a company wide bone marrow drive in early January 2010. Volunteers helped facilitate the drive by helping employees submit a buccal swab at the corporate office. Many employees registered for more information on how to become more involved in helping the cause of finding a cure for leukemia.
To extend its efforts in philanthropy, Central Payment also made a $25,000 contribution to the Lucile Packard Children's Hospital at Stanford. The donation was made in honor of Barry Pham, a former patient who passed away earlier this year after a long courageous battle with leukemia.
The recent donation continues the company's generous gestures to non-profit organizations that have helped many causes. In 2008, Central Payment made an annual commitment to contribute to Sunny Hills Services, a non-profit child welfare organization dedicating to helping at-risk children and adolescents.
Central Payment has also announced that at the beginning of each calendar year, it will select four to six organizations to receive official corporate support and contributions. In addition, the Company has established a matching contribution process by which it will make commensurate donations, subject to approval by management, for contributions made by employees and sales partners.
About Central Payment Corporation
Central Payment ("CPAY") is a leading national provider of transaction processing services. As one of the fastest growing payment processors in the country, CPAY provides innovative electronic technology solutions, personal service and competitive pricing to more than 35,000 businesses across the country. It annually processes in excess of $2.5 billion in transactions.
Approximately every 4 minutes one person in the United States is diagnosed with a blood cancer. An estimated combined total of nearly 140,000 people in the United States alone will be diagnosed with leukemia, lymphoma or myeloma this year.